BioAge Labs, Inc.

MUN:Y7G Stock Report

Market Cap: €813.1m

BioAge Labs Management

Management criteria checks 2/4

BioAge Labs' CEO is Kristen Fortney, appointed in Apr 2015, has a tenure of 9.5 years. total yearly compensation is $1.38M, comprised of 35.7% salary and 64.3% bonuses, including company stock and options. directly owns 3.38% of the company’s shares, worth €27.47M. The average tenure of the management team and the board of directors is 3.8 years and 0.6 years respectively.

Key information

Kristen Fortney

Chief executive officer

US$1.4m

Total compensation

CEO salary percentage35.7%
CEO tenure9.5yrs
CEO ownership3.4%
Management average tenure3.8yrs
Board average tenureless than a year

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Kristen Fortney's remuneration changed compared to BioAge Labs's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$62m

Mar 31 2024n/an/a

-US$66m

Dec 31 2023US$1mUS$493k

-US$64m

Compensation vs Market: Kristen's total compensation ($USD1.38M) is about average for companies of similar size in the German market ($USD1.45M).

Compensation vs Earnings: Insufficient data to compare Kristen's compensation with company performance.

CEO

Kristen Fortney (41 yo)

9.5yrs

Tenure

US$1,382,720

Compensation

Dr. Kristen Fortney, PhD, serves as Member of Advisory Board at Known Medicine Inc. since April 2022. She co-founded BioAge Labs, Inc. in 2015 and serves as Chief Executive Officer, President, Treasurer, S...

Leadership Team

NamePositionTenureCompensationOwnership
Kristen Fortney
Co-Founder9.5yrsUS$1.38m3.38%
€ 27.5m
Eric Morgen
Co-Founder4.4yrsUS$872.80k0.19%
€ 1.5m
Paul Rubin
Chief Medical Officer & Executive VP of Research4.4yrsUS$840.83kno data
Dov Goldstein
Chief Financial Officer2.9yrsno data0.063%
€ 508.7k
Ralph Scarborough
Vice President of Finance & Accounting3.5yrsno datano data
Rusty Montgomery
Senior Vice President of Researchno datano datano data
Julie Gammelgard
Senior Vice President of People2.8yrsno datano data
Peng Leong
Chief Business Officer & Therapeutic Area Head of Brain Aging5.6yrsno datano data
Carrie-Lynn Furr
Senior Vice President of Regulatory Affairs4.8yrsno datano data
Justin Rebo
Senior Vice President of Translational Aging Biology3.5yrsno datano data
BJ Sullivan
Chief Strategy Officer3.8yrsno datano data
Ann Neale
Chief Development Officer2.9yrsno datano data

3.8yrs

Average Tenure

49.5yo

Average Age

Experienced Management: Y7G's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kristen Fortney
Co-Founder9.5yrsUS$1.38m3.38%
€ 27.5m
Eric Morgen
Co-Founder7.3yrsUS$872.80k0.19%
€ 1.5m
James Healy
Independent Directorless than a yearno datano data
Jean-Pierre Garnier
Independent Chairman of the Boardless than a yearno datano data
Patrick Gerald Enright
Independent Directorless than a yearno datano data
Vijay Pande
Independent Director7.3yrsno datano data
Michael Davidson
Independent Directorless than a yearno datano data
G. Alexander Fleming
Member of Scientific Advisory Boardless than a yearno datano data
William Evans
Member of Scientific Advisory Boardless than a yearno datano data
Caroline Apovian
Member of Scientific Advisory Boardless than a yearno datano data
Rekha Hemrajani
Independent Director3.2yrsUS$40.00k0%
€ 0
Timothy Rolph
Member of Scientific Advisory Boardless than a yearno datano data

0.6yrs

Average Tenure

59yo

Average Age

Experienced Board: Y7G's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.